Medtronic Hopes To Refine Renal Denervation Hypertension Therapy With New Trial

 
• By Reed Miller

The 50-patient SPYRAL DYSTAL trial will evaluate the benefits of a new targeted renal denervation approach with the Symplicity Spyral renal denervation system in patients with uncontrolled hypertension.

Blood pressure measuring. Doctor and patient. Health care.
• Source: shutterstock.com

More from Clinical Trials

More from R&D